Tioga Cardiovascular is a healthcare company providing valve replacement solutions for mitral and tricuspid applications.
Tioga Cardiovascular has raised $22.9M in total funding. The most recent round was Series D. The last funding was announced in September 2025.
Tioga Cardiovascular's investors include Cormorant Asset Management, Shifamed, AMED Ventures, The Capital Partnership, PA MedTech VC Fund.
Tioga Cardiovascular is headquartered in Campbell, United States.
Tioga Cardiovascular is a healthcare company providing valve replacement solutions for mitral and tricuspid applications.
Tioga Cardiovascular is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tioga Cardiovascular — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/tioga-cardiovascular. Accessed September 14, 2026.
VCBacked. (2025). Tioga Cardiovascular — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/tioga-cardiovascular
{{cite web |title=Tioga Cardiovascular — Funding & Investors |url=https://www.vcbacked.co/company/tioga-cardiovascular |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated